This is a preview of subscription content, log in via an institution to check access.
Notes
Cardiovascular Disease Policy
National Health and Nutrition Examination Survey
Prospective Study of Pravastatin in the Elderly at Risk of Vascular Disease
References
Odden MC, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Annals of Internal Medicine 162: 533-41, No. 8, 12 Apr 2015. Available from: URL: http://dx.doi.org/10.7326/M14-1430
Rich MW. Cost-effectiveness of statins in older adults: further evidence that less is more. Annals of Internal Medicine 162: 590-1, No. 8, 12 Apr 2015. Available from: URL: http://dx.doi.org/10.7326/M15-0535
Rights and permissions
About this article
Cite this article
Should statins be used for primary prevention in the elderly?. PharmacoEcon Outcomes News 727, 29 (2015). https://doi.org/10.1007/s40274-015-2113-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2113-y